Neofox v0.5.0 release notes Major changes Update to NetMHCpan 4.1 Update to NetMHCIIpan 4.0 Integrate PRIME (Schmidt et al, 2021) as an additional feature Ambiguous MHC allele representations are resolved now using IMGT/HLA database Support for a more flexible mutation model not requiring the wild type sequence Generator rate for alternatively defined neoepitopes (Rech et al, 2018) is included for MHC-I and MHC-II Extended support for Python 3.6, 3.7 and 3.8 Minor changes The neoantigen unique identifier is removed from the tabular output The order of columns in the tabular output is changed to improve readability The affinity threshold is now a parameter (--affinity-threshold) with default value 500000 nM (ie: virtually dis...
Background: Tumor-specific mutations form novel immunogenic peptides called neoantigens. Neoantigens...
Neoantigens are newly formed peptides formed by somatic mutations that are capable of inducing tumor...
Tumor antigens can emerge through multiple mechanisms, including translation of non-coding genomic r...
Major changes Added a model for epitopes Optionally, output a table with all annotated epitopes obt...
Major Changes The annotation of neoantigen candidates from mouse are supported Uniprot instead of e...
Somatic variations are frequent and important drivers in cancers. Amino acid substitutions can yield...
Annotation of mutated peptide sequences (mps) with published or novel potential neo-epitope descript...
Neoantigens are novel peptide sequences resulting from sources such as somatic mutations in tumors. ...
abstract: Cells become cancerous due to changes in their genetic makeup. In cancers, an altered amin...
Neoantigens are newly formed peptides created from somatic mutations that are capable of inducing tu...
BACKGROUND: Next generation sequencing has yielded an unparalleled means of quickly determining the ...
Summary: Computational diagnosis of amino acid variants in the human exome is the first step in asse...
Table S1. Top mutated genes with predicted HLA Class I binding neo-peptides in 147 lung adenocarcino...
BACKGROUND The use of next-generation sequencing technologies has enabled the rapid identificatio...
BACKGROUND: Perturbed posttranslational modification (PTM) landscapes commonly cause pathological ph...
Background: Tumor-specific mutations form novel immunogenic peptides called neoantigens. Neoantigens...
Neoantigens are newly formed peptides formed by somatic mutations that are capable of inducing tumor...
Tumor antigens can emerge through multiple mechanisms, including translation of non-coding genomic r...
Major changes Added a model for epitopes Optionally, output a table with all annotated epitopes obt...
Major Changes The annotation of neoantigen candidates from mouse are supported Uniprot instead of e...
Somatic variations are frequent and important drivers in cancers. Amino acid substitutions can yield...
Annotation of mutated peptide sequences (mps) with published or novel potential neo-epitope descript...
Neoantigens are novel peptide sequences resulting from sources such as somatic mutations in tumors. ...
abstract: Cells become cancerous due to changes in their genetic makeup. In cancers, an altered amin...
Neoantigens are newly formed peptides created from somatic mutations that are capable of inducing tu...
BACKGROUND: Next generation sequencing has yielded an unparalleled means of quickly determining the ...
Summary: Computational diagnosis of amino acid variants in the human exome is the first step in asse...
Table S1. Top mutated genes with predicted HLA Class I binding neo-peptides in 147 lung adenocarcino...
BACKGROUND The use of next-generation sequencing technologies has enabled the rapid identificatio...
BACKGROUND: Perturbed posttranslational modification (PTM) landscapes commonly cause pathological ph...
Background: Tumor-specific mutations form novel immunogenic peptides called neoantigens. Neoantigens...
Neoantigens are newly formed peptides formed by somatic mutations that are capable of inducing tumor...
Tumor antigens can emerge through multiple mechanisms, including translation of non-coding genomic r...